Research and innovation news

Two new Cochrane reviews show strong and consistent evidence that Human papillomavirus (HPV) vaccines are effective in preventing cervical cancer and pre-cancerous changes

The parents of a three-year-old boy born with a life-limiting genetic condition are now excited for his future after he received revolutionary stem cell gene therapy treatment developed in Manchester.

A former Lord Mayor of Manchester has become the 3,000th person in GM to take part in research aimed at understanding and tackling the higher rates of serious disease in South Asian people.

A new study has shown that an existing drug used by the NHS could be repurposed to prevent breast cancer in pre-menopausal women.

A ground-breaking research study treating rare genetic conditions in newborn babies has reached a major milestone with the recruitment of its 1,000th baby at MFT.

Three new studies to improve vaccinations for severe acute respiratory infections have launched in Manchester thanks to support from NIHR Greater Manchester Commercial Research Delivery Centre.

Manchester University NHS Foundation Trust has strengthened its partnership with medical technology company Medtronic, with an agreement to co-develop new health technology solutions.